NATALIE GIBSON: Open Payments
NPI 1497390793 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,858 in 232 payments from 21 companies in 2025. Trend: 2023 $3,153 · 2024 $2,609 · 2025 $3,858
Food & beverage: $3,494Education: $364
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $474 |
| ABBVIE INC. | 27 | $427 |
| Galderma Laboratories, L.P. | 42 | $375 |
| Regeneron Healthcare Solutions, Inc. | 10 | $295 |
| MAYNE PHARMA COMMERCIAL LLC | 24 | $282 |
| LEO Pharma Inc. | 16 | $257 |
| UCB, Inc. | 10 | $249 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $248 |
| Lilly USA, LLC | 11 | $247 |
| Novartis Pharmaceuticals Corporation | 9 | $215 |
Products named: TREMFYA, DUPIXENT, RINVOQ, ADBRY, Bimzelx, TALTZ, COSENTYX, NEMLUVIO.
Industry payments across TX — which companies pay providers there.
